WEBCAST: Digital developments and precision medicine in paediatric growth disorder management

We value your opinion: please complete our evaluation form

Question Title

* 1. Quality of the webcast

How useful for your professional activity did you find this webcast?

Question Title

* 2. What was your overall impression of this webcast?

  Excellent Good Fairly good Poor Very poor
Programme
Organisation

Question Title

* 3. What was the best aspect of this webcast?

Question Title

* 4. What was the worst aspect of this webcast?

Question Title

* 5. Relevance of the webcast

Did the webcast fulfil your educational goals and expected learning outcomes?

  Very much Somewhat Not much Not at all Undecided
Explain current practice gaps in the management of short stature
Gain knowledge of digital programming of primary care height measurement to detect abnormalities of growth.
Awareness of and confidence in the use of digital technology to improve management of growth, as well as patient self-management
Debate what can be learnt from the use of digital tools in other endocrine disorders

Question Title

* 6. How useful to you personally was each session?

  Extremely useful Useful Fairly useful Not useful  Undecided/DNA
Digital interpretation of primary care height measurements to facilitate early diagnosis
Application of digital resources to growth disorder management
Growth hormone adherence management using digital technology

Question Title

* 7. Was the presented information well balanced and consistently supported by a valid scientific evidence base?

Question Title

* 8. Suitability of formats used during the webcast

Was there adequate time available for questions and answers and learner engagement?

Question Title

* 9. Ways the webcast affects clinical practice

Will the information you learnt be implemented in your practice?

Question Title

* 10. Commercial bias

Did all the faculty members provide their potential conflict of interest declarations in their presentations?

Question Title

* 11. Do you agree that the information was overall free of commercial and other bias?

Question Title

* 12. Do you have any final questions or comments?

T